| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA130615
Max Phase: Preclinical
Molecular Formula: C25H19NO4
Molecular Weight: 397.43
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: O=C(Nc1ccccc1C(=O)O)c1ccc(COc2ccc3ccccc3c2)cc1
Standard InChI: InChI=1S/C25H19NO4/c27-24(26-23-8-4-3-7-22(23)25(28)29)19-11-9-17(10-12-19)16-30-21-14-13-18-5-1-2-6-20(18)15-21/h1-15H,16H2,(H,26,27)(H,28,29)
Standard InChI Key: QQYJPVLTXFQSIE-UHFFFAOYSA-N
Associated Targets(Human)
Homo sapiens 32628 Activities
Associated Targets(non-human)
RBL-1 51 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 397.43 | Molecular Weight (Monoisotopic): 397.1314 | AlogP: 5.37 | #Rotatable Bonds: 6 |
| Polar Surface Area: 75.63 | Molecular Species: ACID | HBA: 3 | HBD: 2 |
| #RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 3.55 | CX Basic pKa: | CX LogP: 5.93 | CX LogD: 2.57 |
| Aromatic Rings: 4 | Heavy Atoms: 30 | QED Weighted: 0.46 | Np Likeness Score: -0.82 |
References
| 1. Hasegawa M, Takenouchi K, Takahashi K, Takeuchi T, Komoriya K, Uejima Y, Kamimura T.. (1997) Novel naphthalene derivatives as inhibitors of human immunoglobulin E antibody production., 40 (4): [PMID:9046329] [10.1021/jm9605041] |
Source
Source(1):